Comparative analysis of the 16S to 23S ribosomal intergenic spacer sequences of Bacillus thuringiensis strains and subspecies and of closely related species.

Applied and Environmental Microbiology
S N BourqueR C Levesque

Abstract

Bacillus thuringiensis spacer regions between the 16S and 23S rRNAs were amplified with conserved primers, designated 19-mer and 23-mer primers. A spacer region of 144 bp was determined for all of 6 B. thuringiensis strains, 7 B. thuringiensis subspecies, and 11 B. thuringiensis field isolates, as well as for the closely related species Bacillus cereus and Bacillus anthracis. Computer analysis and alignment of nucleotide sequences identified three mutations and one deletion in the intergenic spacer region (ISR) of B. thuringiensis subsp. kurstaki HD-1 when compared with ISR sequences from other subspecies. The same differences were identified between the ISR of B. thuringiensis strains and the ISR of B. cereus and B. anthracis. These minor differences do not seem to be sufficient to allow the design of a species-specific oligonucleotide probe.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Aug 1, 1991·PCR Methods and Applications·T BarryF Gannon
Jun 1, 1989·Microbiological Reviews·H Höfte, H R Whiteley
Jun 1, 1989·Journal of Clinical Microbiology·M N StarnbachL S Tompkins
Mar 1, 1986·Microbiological Reviews·A I AronsonP Dunn
Jan 1, 1987·Critical Reviews in Biotechnology·R E AndrewsL A Bulla
Jan 1, 1986·Annual Review of Microbiology·H R Whiteley, H E Schnepf
Nov 1, 1972·Journal of General Microbiology·H J Somerville, M L Jones
Jan 11, 1984·Nucleic Acids Research·J DevereuxO Smithies

❮ Previous
Next ❯

Citations

Mar 3, 2004·Microbiology·Benjamin CandelonAlexei Sorokin
Feb 13, 2009·PloS One·Shalini PorwalVipin Chandra Kalia
Jun 1, 2000·Applied and Environmental Microbiology·E HelgasonA B Kolstø
Aug 25, 2001·FEMS Microbiology Letters·B M HansenN B Hendriksen
May 2, 2000·Applied and Environmental Microbiology·N CharniN Rugani
Jul 28, 2001·Journal of Applied Microbiology·K B Joung, J C Côté
Aug 7, 2003·Applied and Environmental Microbiology·Yu-Hsiu ChangHwan-Wun Liu
Jun 13, 2012·The Journal of General and Applied Microbiology·Jawahar KataraSarvjeet Kaur
Aug 19, 2014·Current Microbiology·Karina GarcíaPatricia Gomez de Leon
Feb 8, 2006·Applied and Environmental Microbiology·Daniele DaffonchioSara Borin
Dec 1, 2000·Applied and Environmental Microbiology·J C Cho, J M Tiedje
Jun 17, 2003·International Journal of Systematic and Evolutionary Microbiology·Dong Xu, Jean-Charles Côté
May 7, 2002·Canadian Journal of Microbiology·Yuming BaiBrian T Driscoll
Nov 12, 2005·Analytical and Bioanalytical Chemistry·Katie A EdwardsAntje J Baeumner
Apr 23, 1999·Journal of Applied Microbiology·M M LecadetI Thiéry
Jun 7, 2008·Canadian Journal of Microbiology·Wen-Wen ZhouTian-Gui Niu
Oct 12, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Carla C C R de Carvalho, Maria José Caramujo
May 9, 1998·Applied and Environmental Microbiology·V Mäntynen, K Lindström
Jun 24, 2000·FEMS Immunology and Medical Microbiology·A J Martínez-MurciaM J Figueras
Feb 24, 2001·Biosensors & Bioelectronics·S S IqbalJ P Chambers
Jul 5, 2003·Journal of Clinical Microbiology·Kwan Soo KoYoon-Hoh Kook
Jan 13, 2004·Journal of Clinical Microbiology·William HurtleDavid Norwood
Jun 5, 2003·Journal of Microbiological Methods·Alvin FoxRobert L Price

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.